Cargando...
Efficacy of Pembrolizumab and Nivolumab in Crossing the Blood Brain Barrier
Metastatic brain tumors are the leading cause of central nervous system malignancies in adults, surpassing primary central nervous system with non-small cell lung cancer, accounting for more than 50% of all cases. The emergence of immunotherapies such as antibodies targeting the immune check points...
Gardado en:
| Publicado en: | Cureus |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Cureus
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559690/ https://ncbi.nlm.nih.gov/pubmed/31245230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4446 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|